Stay updated on Safety & Immune Response of eOD-GT8 & g28v2 mRNA-1644 Clinical Trial
Sign up to get notified when there's something new on the Safety & Immune Response of eOD-GT8 & g28v2 mRNA-1644 Clinical Trial page.

Latest updates to the Safety & Immune Response of eOD-GT8 & g28v2 mRNA-1644 Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe study record is available again, presenting details of the Phase 1 HIV vaccine trial, including its interventions, eligibility criteria, study locations, and outcome measures.SummaryDifference58%

- Check20 days agoChange DetectedThe site footer revision changes from v3.7.2 to v3.8.0, while the study page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check27 days agoChange DetectedA site-wide NIH notice was added announcing updates and FAQs about the transition from “Artificial Intelligence” to “Super Intelligence” terminology.SummaryDifference1%

- Check34 days agoChange DetectedThe footer revision number changes from v3.7.1 to v3.7.2 on the 403 error page.SummaryDifference0.2%

- Check41 days agoChange DetectedThe site footer revision indicator changes from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check61 days agoChange DetectedThe page now shows a 403 Forbidden error instead of the study record details, indicating access restrictions to the content; the UI displays an error message and a 403 header.SummaryDifference20%

Stay in the know with updates to Safety & Immune Response of eOD-GT8 & g28v2 mRNA-1644 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety & Immune Response of eOD-GT8 & g28v2 mRNA-1644 Clinical Trial page.